{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:51:36Z","timestamp":1789707096395,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["413584448"],"award-info":[{"award-number":["413584448"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390649896"],"award-info":[{"award-number":["390649896"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Persistent symptoms after initial COVID-19 infection are common and are frequently referred to by the umbrella terms \u201cpost-COVID syndrome\u201d and \u201clong COVID\u201d. The sheer number of affected patients pose an increasing challenge to healthcare systems worldwide. To date, our understanding of the pathophysiology of the post-COVID syndrome remains poor and the extent to which persistent cardiopulmonary abnormalities contribute to the symptom complex is unclear. We sought to determine the presence and impact of cardiopulmonary sequelae after COVID-19 in longitudinal assessment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We report on 71 patients who underwent comprehensive, longitudinal testing in regular intervals for up to 12\u00a0months after their initial COVID-19 diagnosis. Testing included pulmonary function testing, cardiopulmonary exercise testing, dedicated left and right heart echocardiography, lung ultrasonography, and cardiac MRI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results demonstrate that subjective quality of life after COVID-19 (EQ-5D visual acuity scale, VAS, 67.4 for patients treated as outpatient, 79.2 for patients admitted to the general floor, 71.8 for patients treated in an ICU) is not related to the severity of the initial infection. Maximal exercise capacity is also reduced (VO<jats:sub>2<\/jats:sub>max 79% predicted, SD\u2009\u00b1\u200919%); however, this is driven in large parts by patients who had initially required ICU-level of care. The degree of objective reduction in exertion did not correlate with quality of life scores. Pulmonary function testing revealed mild and persistent reduction in D<jats:sub>LCO<\/jats:sub> over the first 12\u00a0months without significant restrictive or obstructive lung disease. Left and right heart function was intact with good RV function and intact RV\/PA coupling, imaging findings suggestive of myocarditis were uncommon (7% of patients).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A reduction in exercise capacity after COVID-19 is common, but is most prominent in patients previously treated in the ICU and more likely related to deconditioning or fatigue than to cardiopulmonary impairment. Subjective quality of life scores are independent of the severity of initial infection and do not correlate with objective measures of cardiopulmonary function. In our cohort, persistent cardiopulmonary impairment after COVID-19 was uncommon. The post-COVID syndrome is unlikely to be the result of cardiopulmonary sequalae and may reflect a post-ICU syndrome in some.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> Registered on clinicaltrials.gov (NCT04442789), Date: June 23, 2020<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02173-9","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T16:08:13Z","timestamp":1663776493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Long-term comprehensive cardiopulmonary phenotyping of COVID-19"],"prefix":"10.1186","volume":"23","clinical-trial-number":[{"clinical-trial-number":"nct04442789","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lucas M.","family":"Kimmig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvonimir A.","family":"Rako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan Tolou","family":"G.S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Roller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Grimminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Vad\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khodr","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Matt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"2173_CR1","unstructured":"JHU. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) 2022. https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"2173_CR2","unstructured":"WHO. The true death toll of COVID-19 - Estimating global excess mortality: World Health Organization; 2021. https:\/\/www.who.int\/data\/stories\/the-true-death-toll-of-covid-19-estimating-global-excess-mortality."},{"issue":"6","key":"2173_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carfi","year":"2020","unstructured":"Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603\u20135.","journal-title":"JAMA"},{"key":"2173_CR4","unstructured":"COVID-19 rapid guideline: managing the long- term effects of COVID-19: National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP); 2021. https:\/\/www.nice.org.uk\/guidance\/ng188\/resources\/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742."},{"key":"2173_CR5","unstructured":"Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021; 2021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/articles\/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk\/26april2020to1august2021."},{"issue":"1","key":"2173_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12931-020-01429-6","volume":"21","author":"Y Huang","year":"2020","unstructured":"Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163.","journal-title":"Respir Res"},{"issue":"11","key":"2173_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265\u201373.","journal-title":"JAMA Cardiol"},{"key":"2173_CR8","first-page":"66","volume":"89","author":"SA Guler","year":"2021","unstructured":"Guler SA, Ebner L, Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;89:66.","journal-title":"Eur Respir J"},{"key":"2173_CR9","first-page":"6","volume":"89","author":"T Sonnweber","year":"2020","unstructured":"Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur Respir J. 2020;89:6.","journal-title":"Eur Respir J"},{"issue":"2","key":"2173_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1183\/13993003.01763-2021","volume":"58","author":"R Naeije","year":"2021","unstructured":"Naeije R, Caravita S. Phenotyping long COVID. Eur Respir J. 2021;58(2):89.","journal-title":"Eur Respir J"},{"issue":"2","key":"2173_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1183\/13993003.01578-2021","volume":"58","author":"J Motiejunaite","year":"2021","unstructured":"Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, Vidal-Petiot E, et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J. 2021;58(2):9.","journal-title":"Eur Respir J"},{"issue":"2","key":"2173_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1183\/13993003.00996-2021","volume":"58","author":"I Skjorten","year":"2021","unstructured":"Skjorten I, Ankerstjerne OAW, Trebinjac D, Bronstad E, Rasch-Halvorsen O, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58(2):78.","journal-title":"Eur Respir J"},{"issue":"2","key":"2173_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1183\/13993003.00870-2021","volume":"58","author":"RF Rinaldo","year":"2021","unstructured":"Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2):78.","journal-title":"Eur Respir J"},{"issue":"11","key":"2173_CR14","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1513\/AnnalsATS.202012-1489RL","volume":"18","author":"SJ Abdallah","year":"2021","unstructured":"Abdallah SJ, Voduc N, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A, et al. Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19. Ann Am Thorac Soc. 2021;18(11):1912\u20137.","journal-title":"Ann Am Thorac Soc"},{"key":"2173_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101066","volume":"39","author":"GA Alba","year":"2021","unstructured":"Alba GA, Ziehr DR, Rouvina JN, Hariri LP, Knipe RS, Medoff BD, et al. Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine. 2021;39: 101066.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"2173_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/CCM.0000000000002208","volume":"45","author":"VD Dinglas","year":"2017","unstructured":"Dinglas VD, Aronson Friedman L, Colantuoni E, Mendez-Tellez PA, Shanholtz CB, Ciesla ND, et al. Muscle Weakness and 5-Year Survival in Acute Respiratory Distress Syndrome Survivors. Crit Care Med. 2017;45(3):446\u201353.","journal-title":"Crit Care Med"},{"issue":"3","key":"2173_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1378\/chest.123.3.845","volume":"123","author":"TA Neff","year":"2003","unstructured":"Neff TA, Stocker R, Frey HR, Stein S, Russi EW. Long-term assessment of lung function in survivors of severe ARDS. Chest. 2003;123(3):845\u201353.","journal-title":"Chest"},{"issue":"12","key":"2173_CR18","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s00134-021-06541-9","volume":"47","author":"N Van Aerde","year":"2021","unstructured":"Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Casaer MP, Gunst J, et al. Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study. Intensive Care Med. 2021;47(12):1462\u201371.","journal-title":"Intensive Care Med"},{"issue":"14","key":"2173_CR19","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","volume":"364","author":"MS Herridge","year":"2011","unstructured":"Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293\u2013304.","journal-title":"N Engl J Med"},{"issue":"9","key":"2173_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003773","volume":"18","author":"M Taquet","year":"2021","unstructured":"Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9): e1003773.","journal-title":"PLoS Med"},{"issue":"1","key":"2173_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.amjcard.2005.07.118","volume":"97","author":"JR Silverstein","year":"2006","unstructured":"Silverstein JR, Laffely NH, Rifkin RD. Quantitative estimation of left ventricular ejection fraction from mitral valve E-point to septal separation and comparison to magnetic resonance imaging. Am J Cardiol. 2006;97(1):137\u201340.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2173_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12968-017-0408-9","volume":"20","author":"DR Messroghli","year":"2018","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2018;20(1):9.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"24","key":"2173_CR23","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72(24):3158\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"2173_CR24","first-page":"5","volume":"54","author":"K Tello","year":"2019","unstructured":"Tello K, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, et al. Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension. Eur Respir J. 2019;54:5.","journal-title":"Eur Respir J"},{"key":"2173_CR25","first-page":"45","volume":"8","author":"L Townsend","year":"2021","unstructured":"Townsend L, Dowds J, O\u2019Brien K, Sheill G, Dyer AH, O\u2019Kelly B, et al. Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021;8:45.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"2173_CR26","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1378\/chest.128.4.2247","volume":"128","author":"DS Hui","year":"2005","unstructured":"Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4):2247\u201361.","journal-title":"Chest"},{"key":"2173_CR27","doi-asserted-by":"publisher","first-page":"106394","DOI":"10.1016\/j.rmed.2021.106394","volume":"182","author":"E Ekbom","year":"2021","unstructured":"Ekbom E, Frithiof R, Emilsson \u00d6, Larson IM, Lipcsey M, Rubertsson S, et al. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021;182:106394.","journal-title":"Respir Med"},{"issue":"7","key":"2173_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1513\/AnnalsATS.202011-1452RL","volume":"18","author":"R Mendez","year":"2021","unstructured":"Mendez R, Latorre A, Gonzalez-Jimenez P, Feced L, Bouzas L, Yepez K, et al. Reduced Diffusion Capacity in COVID-19 Survivors. Ann Am Thorac Soc. 2021;18(7):1253\u20135.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"2173_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s15010-022-01755-5","volume":"50","author":"A Fortini","year":"2022","unstructured":"Fortini A, Rosso A, Cecchini P, Torrigiani A, Lo Forte A, Carrai P, et al. One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome. Infection. 2022;50(2):513\u20137.","journal-title":"Infection"},{"issue":"6","key":"2173_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.pulmoe.2021.02.004","volume":"27","author":"AO Peixoto","year":"2021","unstructured":"Peixoto AO, Costa RM, Uzun R, Fraga AMA, Ribeiro JD, Marson FAL. Applicability of lung ultrasound in COVID-19 diagnosis and evaluation of the disease progression: A systematic review. Pulmonology. 2021;27(6):529\u201362.","journal-title":"Pulmonology"},{"issue":"3","key":"2173_CR31","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1148\/radiol.2021211162","volume":"301","author":"D Kravchenko","year":"2021","unstructured":"Kravchenko D, Isaak A, Zimmer S, Mesropyan N, Reinert M, Faron A, et al. Cardiac MRI in patients with prolonged cardiorespiratory symptoms after mild to moderate COVID-19. Radiology. 2021;301(3):E419\u201325.","journal-title":"Radiology"},{"issue":"11","key":"2173_CR32","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1016\/j.jcmg.2020.05.004","volume":"13","author":"L Huang","year":"2020","unstructured":"Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020;13(11):2330\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2173_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamacardio.2021.5505","volume":"7","author":"K Hanneman","year":"2022","unstructured":"Hanneman K, Houbois C, Schoffel A, Gustafson D, Iwanochko RM, Wintersperger BJ, et al. Combined cardiac fluorodeoxyglucose-positron emission tomography\/magnetic resonance imaging assessment of myocardial injury in patients who recently recovered from COVID-19. JAMA Cardiol. 2022;7(3):298\u2013308.","journal-title":"JAMA Cardiol"},{"key":"2173_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7596-1","volume-title":"Self-Reported Population Health: An International Perspective based on EQ-5D","author":"BJ Agota Szende","year":"2014","unstructured":"Agota Szende BJ, Juan C. Self-Reported Population Health: An International Perspective based on EQ-5D. Berlin: Springer; 2014."},{"issue":"1","key":"2173_CR35","doi-asserted-by":"publisher","first-page":"12775","DOI":"10.1038\/s41598-021-91270-8","volume":"11","author":"J Varghese","year":"2021","unstructured":"Varghese J, Sandmann S, Ochs K, Schrempf IM, Frommel C, Dugas M, et al. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021;11(1):12775.","journal-title":"Sci Rep"},{"issue":"3","key":"2173_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1183\/09031936.04.00007104","volume":"24","author":"KC Ong","year":"2004","unstructured":"Ong KC, Ng AW, Lee LS, Kaw G, Kwek SK, Leow MK, et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur Respir J. 2004;24(3):436\u201342.","journal-title":"Eur Respir J"},{"issue":"1","key":"2173_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcrc.2011.07.080","volume":"27","author":"S Benington","year":"2012","unstructured":"Benington S, McWilliams D, Eddleston J, Atkinson D. Exercise testing in survivors of intensive care\u2013is there a role for cardiopulmonary exercise testing? J Crit Care. 2012;27(1):89\u201394.","journal-title":"J Crit Care"},{"key":"2173_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-11-37","volume":"11","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.","journal-title":"BMC Neurol"},{"key":"2173_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110055","volume":"144","author":"R Perrin","year":"2020","unstructured":"Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144: 110055.","journal-title":"Med Hypotheses"},{"issue":"3","key":"2173_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0163-4453(85)92488-0","volume":"10","author":"PO Behan","year":"1985","unstructured":"Behan PO, Behan WM, Bell EJ. The postviral fatigue syndrome\u2013an analysis of the findings in 50 cases. J Infect. 1985;10(3):211\u201322.","journal-title":"J Infect"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02173-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T04:10:13Z","timestamp":1663819813000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02173-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02173-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients consented to the use of their data via the German Center for Lung Research (<i>Deutsches Zentrum f\u00fcr Lungenforschung, DZL<\/i>) consent form. The project was reviewed and is covered under the University of Giessen ethics committee decision (AZ 58\/15) and was performed according to the appropriate regulations and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests related to this work. Dr. Seeger reports personal fees from Actelion, personal fees from Bayer AG, personal fees from Novartis, personal fees from Vectura, personal fees from Medspray, personal fees from United Therapeutics, outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}